CDSCO UID MFG/IVD/2022/000049_1eae2ccdc4b0a1107f727d89bd14a90b_a64e8fb5d4205787b15eecc5df4f4528

COVID 19 RT-qPCR

Promea Therapeutics Private Limited·Device Class Class C·India CDSCO·Brand: ProPCR
Registration details
UID
MFG/IVD/2022/000049_1eae2ccdc4b0a1107f727d89bd14a90b_a64e8fb5d4205787b15eecc5df4f4528
Device class
Class C
Brand name
ProPCR
Approving authority
CDSCO, Zonal office, Hyderabad
Product information
It is used to detect target gene amplification through gene specific primers and probes by using Taq Man Chemistry Method
Similar products (1)
Other products with the same name or brand
Nucleic Acid Extraction Kit
Brand: ProPCR
Promea Therapeutics Private Limited
Class C
Other products from Promea Therapeutics Private Limited
Products from the same license holder (10 products)
TRIPLEX HBV/HCV/HIV RT-PCR
Class D
Inactivation Transport Medium
Class C
Nucleic Acid Extraction Kit
Brand: ProPCR
Class C
Blood Glucose Meter Smart - GDH
Brand: P. falciparum, histidine-rich protein II
Class C
Dengue NS1 Rapid
Class C
HBsAg Rapid Kit
Brand: IgG and IgM
Class D
Blood Glucose Meter- GDH
Brand: P. falciparum, histidine-rich protein II
Class C
Blood Glucose Meter- GOD
Brand: P. falciparum, histidine-rich protein II
Class C
Blood Glucose Meter Smart - GOD
Brand: P. falciparum, histidine-rich protein II
Class C
HCV Rapid
Class D
About this record

COVID 19 RT-qPCR is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000049_1eae2ccdc4b0a1107f727d89bd14a90b_a64e8fb5d4205787b15eecc5df4f4528. This device is marketed under the brand name ProPCR. The license holder is Promea Therapeutics Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO, Zonal office, Hyderabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.